In memory
Umberto Eco and Pancreatic Cancer: Remembering a Literary Giant
The Italian author Umberto Eco died of pancreatic cancer in 2016. Here's what that diagnosis really means, in calm and accurate terms.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
On screen
Umberto Eco was an Italian novelist, philosopher, and semiotician, best known worldwide for his 1980 novel The Name of the Rose and for Foucault's Pendulum. He was also a beloved professor and public intellectual. It was widely reported that he died at his home in Milan on the night of February 19, 2016, at the age of 84, after living with pancreatic cancer. Readers around the world remembered him for the depth, wit, and generosity of his work.
The reality
Pancreatic cancer begins in the pancreas, an organ deep in the abdomen behind the stomach. According to the National Cancer Institute, it can develop from two kinds of cells: exocrine cells and neuroendocrine cells (such as islet cells). The exocrine type is more common and is usually found at an advanced stage. Pancreatic neuroendocrine tumors, also called islet cell tumors, are less common but generally have a better prognosis.
Because the pancreas is located deep inside the body, early symptoms can be vague or easy to overlook, which is part of why this cancer is often found later than many others.
What the story gets right — and what to remember
Public tributes noted that Eco lived with pancreatic cancer before his death. The details a family chooses to share are theirs, and beyond those widely reported facts, the specifics of any person's illness are private. It's worth remembering that pancreatic cancer varies a great deal from person to person — by type, by stage, and by how each individual responds — so one person's story is never a guide to another's, and it is not medical advice.
Awareness, screening & prevention
The National Cancer Institute states that it does not have evidence-based (PDQ) information about screening for pancreatic cancer, and does not have PDQ evidence-based information about its prevention. In plain terms, there is no recommended routine screening test for the general population for this cancer. Anyone with symptoms, worries, or a family history should raise them with a healthcare team, who can look at the individual picture. NCI also offers general overviews of cancer prevention and screening.
Turning a story into something useful
Honoring a writer like Eco can be a calm way to learn the real facts about a disease many people find unsettling. Understanding what pancreatic cancer is, being willing to talk openly with a healthcare team, and sharing accurate information with those we care about are all small, worthwhile steps. Free, reliable cancer education exists so that clear answers are always within reach.
Questions to ask a healthcare team
- What symptoms would be worth discussing with a doctor?
- Does my family history change how I should think about my own risk?
- Where can I find trustworthy, plain-language information about this cancer?
- Who can help if I'm feeling anxious about cancer?